Miles Wright

Kreglinger and Averix Bio Announce Distribution and Supply Agreement

For immediate release: Antwerp, BE (11 March, 2022) Kreglinger Europe NV (Kreglinger) today announces the execution of a Distribution and Supply Agreement with Averix Bio, LLC (“Averix Bio”), a US based, North Carolina-registered company whose office is at 3040 Black Creek Road South, Wilson, N.C. 27893, USA. With this agreement in place, Kreglinger and Averix Bio are poised to […]

Kreglinger and Averix Bio Announce Distribution and Supply Agreement Read More »

Averix Bio Announces Submission of Drug Master File for Cannabidiol

For immediate release:   Wilson, North Carolina (February 22, 2022)  Averix Bio today announces its submission of a  Drug Master File (DMF) to the US Food & Drug Administration (FDA) for cannabidiol (CBD) isolate. Unlike most manufacturers, Averix ingredients are not synthetic but instead made from phytocannabinoid industrial hemp. The submission (DMF 036798) signifies Averix Bio’s

Averix Bio Announces Submission of Drug Master File for Cannabidiol Read More »

Phytocannabinoids vs. Synthetics: Pros & Cons

      Source: FDA   There are two different ways to produce cannabis compounds – either through the traditional grow method which yields phytocannabinoids or from the lab which yields synthetic cannabinoids. The exception to the former is of course the recent production of cannabinoids from microorganisms like yeast; here, we will consider these

Phytocannabinoids vs. Synthetics: Pros & Cons Read More »

Why cGMP Matters

IS YOUR COMPANY cGMP 210/211 COMPLIANT?   A couple of years ago, a friend asked me to teach him how to make cannabidiol (CBD) isolate. A few days later I drove into the country and found him in an actual (and proverbial) barn – dirt floor, tobacco boxes, and threshers from the 1950s. My friend

Why cGMP Matters Read More »